Kuros Biosciences AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,117	859	138	54	61	61
Market Cap Growth	27.38%	523.03%	153.55%	-10.72%	-0.52%	20.93%
Enterprise Value	1,099	846	123	35	37	50
Last Close Price	27.76	-	-	-	1.41	1.41
PS Ratio	10.09	10.66	3.82	2.99	4.57	16.40
PB Ratio	13.61	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	29.94	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	-	393.96	-	-	-	-
P/OCF Ratio	1272.08	256.57	-	-	-	-
EV/Sales Ratio	9.71	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	154.68	385.86	-	-	-	-
EV/EBIT Ratio	260.30	7414.24	-	-	-	-
EV/FCF Ratio	-1522.38	387.93	-	-	-	-
Debt / Equity Ratio	0.02	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.28	0.66	-	-	-	-
Debt / FCF Ratio	-	0.88	-	-	-	-
Net Debt / Equity Ratio	-0.22	-0.28	-0.21	-0.32	-0.34	-0.31
Net Debt / EBITDA Ratio	-2.86	-7.89	4.04	2.95	4.17	2.74
Net Debt / FCF Ratio	24.71	-7.93	1.32	2.86	4.58	2.79
Asset Turnover	1.10	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.14	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.68	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.25	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-8.62%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	2.57%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital Employed (ROCE)	4.60%	0.20%	-8.20%	-14.00%	-11.00%	-13.00%
Earnings Yield	-0.58%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	-0.06%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-36.07%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.